Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Q2: The Doctor Care Anywhere (ASX:DOC) share price is one to watch

The Doctor Care Anywhere Group PLC (ASX:DOC) share price could be one to watch after announcing another strong quarter of growth.

The Doctor Care Anywhere Group PLC (ASX: DOC) share price could be one to watch after announcing another strong quarter of growth.

If you haven’t heard of Doctor Care Anywhere before, it’s a UK-based telehealth business that is looking to provide care through digitally enabled pathways on a platform. It works with a range of health insurers, healthcare providers and corporate customers to connect with patients to deliver a range of telehealth services.

Doctor Care Anywhere Q2 update

It revealed that its ‘underlying revenue’ was £4.8 million ($8.9 million), up 8.1% on the first quarter of 2021. That also represented a 78.1% increase on the second quarter of 2020 (the prior corresponding period).

Doctor Care Anywhere also revealed some other statistics.

It said there its ‘activated lives’ (the number of people who have signed up for the company’s service and entered their details) had increased 12.7% over the quarter and 90.1% year on year.

The company also achieved a record 2,146 consultations on a single day, up 33% on the previous highest day. It saw record consultation volumes seen across all days of the week at the quarter end, demonstrating continued demand as the UK economy unlocks.

In total, it delivered 89,400 consultations during the quarter, down 1.3% on the first quarter of 2021 due to an anticipated shortage of GPs recalled to do the national vaccination program. However, that was still a 69.1% increase year on year.

A recruitment drive added 71 new GPs to the platform in the second quarter of 2021, bringing the panel to 315. There are a further 100 GPs in the pipeline, which would provide appointment capacity per month of up to 45,000. Further recruitment is underway.

Other highlights

The company also said that its diagnostic referral volumes were up 34.4% on the first quarter.

It has strengthened its Nuffield Health partnership with an agreement for unique integrated primary care service.

Doctor Care Anywhere finished the period if £31.5 million of cash, meaning it’s well funded to pursue more growth.

Summary thoughts on Doctor Care Anywhere and the share price

The business is expecting FY21 revenue to at least double compared to FY20. That’s a very strong increase in my opinion. If it can continue a high double digit revenue growth rate then Doctor Care Anywhere could certainly be one to watch. Digitally-enabled ways of doing things could be a good growth area. Think about how strongly digital retail is growing.

It’s one of the ASX growth shares on my watchlist.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.
Skip to content